Results 21 to 30 of about 471 (127)

Pharmacological Profile of Cefepime Plus Enmetazobactam in the Treatment of Complicated Urinary Tract Infections Including Catheter-Associated Urinary Tract Infection (CAUTI)

open access: yesAmrita Journal of Medicine
Cefepime plus enmetazobactam represents a breakthrough novel combination of a β-lactam antibiotic and a β-lactamase inhibitor, which demonstrates extensive antibacterial activity against a wide range of both gram-positive and gram-negative bacteria.
Raja Chakraverty   +2 more
doaj   +2 more sources

Microbiological, Clinical, and PK/PD Features of the New Anti-Gram-Negative Antibiotics: β-Lactam/β-Lactamase Inhibitors in Combination and Cefiderocol—An All-Inclusive Guide for Clinicians [PDF]

open access: yesPharmaceuticals, 2022
Bacterial resistance mechanisms are continuously and rapidly evolving. This is particularly true for Gram-negative bacteria. Over the last decade, the strategy to develop new β-lactam/β-lactamase inhibitors (BLs/BLIs) combinations has paid off and ...
Luigi Principe   +11 more
doaj   +2 more sources

Novel Antimicrobial Agents for Gram-Negative Pathogens

open access: yesAntibiotics, 2023
Gram-negative bacterial resistance to antimicrobials has had an exponential increase at a global level during the last decades and represent an everyday challenge, especially for the hospital practice of our era.
Marios Karvouniaris   +6 more
doaj   +2 more sources

Evaluation of cefepime/enmetazobactam gradient strip and disk diffusion test for CTX-M–producing

open access: yesJournal of Global Antimicrobial Resistance
: The global spread of extended-spectrum β-lactamase (ESBL)–producing enterobacterales represents a major clinical challenge often requiring carbapenem use with the consequent risk of selecting carbapenemase-producing strains. Recently, new β-lactam plus
Alessandro Bondi   +5 more
doaj   +3 more sources

A Review of β-Lactamase Inhibitors in Clinical Use and Development: Mechanisms, Spectrum, and Therapeutic Applications

open access: yesInternational Journal of Microbiology
β-Lactam antibiotics have long served as a cornerstone for treating bacterial infections. However, their widespread and often indiscriminate use has fueled the emergence of multidrug-resistant Gram-negative pathogens, primarily through the production and
Mohammad Javad Roustaye Gourabi   +8 more
doaj   +2 more sources

A brief historical perspective of antimicrobial resistance in India [PDF]

open access: yesmBio
Antimicrobial resistance (AMR) is the ability of microbes to survive exposure to antimicrobials that were once effective against them. This is a major global crisis and public health challenge of the 21st century that is declared as a silent pandemic ...
Maneesh Paul Satyaseela
doaj   +2 more sources

Spectrophotometric determination of cefepime and enmetazobactam in pharmaceutical formulations and human plasma using chemometric modeling, metaheuristic wavelength selection, and comprehensive sustainability assessment [PDF]

open access: yesBMC Chemistry
The recently introduced cefepime–enmetazobactam (CEF–ENM) combination requires reliable analytical methods for pharmaceutical quality control and proof-of-concept bioanalytical evaluation.
Ahmed Farghaly   +6 more
doaj   +2 more sources

Pharmacokinetics of Cefepime-Enmetazobactam in the Cerebrospinal Fluid of Rats

open access: yes
Background: Nosocomial meningitis caused by Gram-negative pathogens remains a major therapeutic challenge, particularly with the increasing prevalence of multidrug-resistant bacteria that restrict available treatment options. Cefepime is standard care, but its activity is increasingly compromised by β-lactamase–mediated resistance [1].
Chauzy, Alexia   +5 more
core   +3 more sources

Efficacy of treatment options for complicated urinary tract infections including acute pyelonephritis: a systematic literature review and network meta-analysis [PDF]

open access: yesJournal of Comparative Effectiveness Research
Aim: Compared with uncomplicated urinary tract infections (UTIs), complicated UTIs (cUTIs) including acute pyelonephritis (AP) presentwith significant morbidity, a higher risk of treatment failure and typically require longer courses of treatment, or ...
Florian Wagenlehner   +8 more
doaj   +2 more sources

Home - About - Disclaimer - Privacy